Geovax Labs Inc Financials

GOVXW

FY2025 annual

Revenue $2.5M -37.1% YoY

Net Income -$21.5M +14.1% YoY

EPS (Diluted) Not reported for FY2025

Free Cash Flow -$21.5M +12.9% YoY

Source SEC Filings (10-K/10-Q) Latest period Q1 FY2026, ended Mar 31, 2026 Reported May 14, 2026 Currency USD FYE December

Geovax Labs Inc (GOVXW) reported $2.5M in revenue for fiscal year 2025, down 37.1% from the prior fiscal year. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI GOVXW FY2025 2026-08-15

GeoVax operates as a cash-funded R&D platform, with financing inflows rather than product revenue carrying the business.

In FY2025, cash of $3.1M covered only 0.1x the year’s operating cash use of -$21.5M, and even after financing inflows of $19.1M cash still fell from $5.5M in FY2024. That ties the balance sheet to the cash flow statement: the operating model was funded mainly by new capital, while commercial receipts of just $2.5M were too small to support the research program.

R&D spending of $18.1M in FY2025 was more than 7x revenue of $2.5M and about 3x SG&A of $6.0M, so the loss profile comes primarily from development activity rather than from a sales infrastructure built for current demand.

Capital intensity is low: capex was only $28K against free cash flow of -$21.5M, while total liabilities fell to $2.5M from $3.1M. That means cash consumption is tied mostly to ongoing operating research, not to maintaining heavy physical assets or carrying meaningful long-term debt.

Financial Health Signals

Financial Health Score 31/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Geovax Labs Inc's business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Geovax Labs Inc's reported operating margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 26/100.

Growth

Geovax Labs Inc's revenue declined 37.1% year-over-year, from $4.0M to $2.5M. This contraction results in a growth score of 2/100.

Leverage

Geovax Labs Inc has a moderate D/E ratio of 0.66. This balance of debt and equity financing earns a leverage score of 54/100.

Liquidity

With a current ratio of 2.74, Geovax Labs Inc holds $2.74 in current assets for every $1 of short-term obligations. This comfortable liquidity earns a score of 73/100.

Cash Flow

Geovax Labs Inc's reported free cash flow margin for fiscal year 2025 is below the lowest share of revenue this page publishes, so the figure is not shown here. This dimension scores 2/100.

Returns

Geovax Labs Inc posts a -561.2% return on equity (ROE), meaning it loses $561 for every $100 of shareholders' equity. This results in a returns score of 31/100. This is down from -495.0% the prior year.

Piotroski F-Score Partial

1/7

Geovax Labs Inc passes 1 of 7 computable financial strength tests (2 of the nine could not be computed from available data). No profitability signals pass, 1 of 2 leverage/liquidity signals pass, neither operating efficiency signal passes.

Earnings Quality No Cash Backing

N/A

Geovax Labs Inc reported a net loss of $21.5M while operations used $21.5M of cash. With neither figure positive, the ratio between the two carries no quality signal.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$2.5M

YoY-37.1%

5Y CAGR+6.4%

Geovax Labs Inc generated $2.5M in revenue in fiscal year 2025. This represents a decrease of 37.1% from the prior year.

EBITDA

-$21.6M

YoY+13.9%

Geovax Labs Inc's EBITDA was -$21.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization. This represents an increase of 13.9% from the prior year.

Net Income

-$21.5M

YoY+14.1%

Geovax Labs Inc reported -$21.5M in net income in fiscal year 2025. This represents an increase of 14.1% from the prior year.

EPS (Diluted)

Not reported for fiscal year 2025.

Cash & Balance Sheet

Free Cash Flow

-$21.5M

YoY+12.9%

Geovax Labs Inc recorded an outflow of $21.5M in free cash flow in fiscal year 2025, representing a cash shortfall after capex. This represents an increase of 12.9% from the prior year.

Cash & Debt

$3.1M

YoY-44.0%

5Y CAGR-20.8%

10Y CAGR+11.3%

Geovax Labs Inc held $3.1M in cash as of fiscal year 2025; long-term debt is not reported for that period.

Shares Outstanding

Geovax Labs Inc had 2M shares outstanding in fiscal year 2025.

Dividends Per Share

Not reported for fiscal year 2025.

Margins & Returns

Return on Equity

-561.2%

YoY-66.1pp

5Y CAGR-530.2pp

Geovax Labs Inc's ROE was -561.2% in fiscal year 2025, measuring profit generated per dollar of shareholder equity. This is down 66.1 percentage points from the prior year.

Gross Margin

Not reported for fiscal year 2025.

Operating Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Net Margin

Not shown for fiscal year 2025: the reported ratio is below -100.0% of revenue, so it does not read as a share of revenue.

Capital Allocation

R&D Spending

$18.1M

YoY-23.6%

5Y CAGR+49.3%

10Y CAGR+26.8%

Geovax Labs Inc invested $18.1M in research and development in fiscal year 2025. This represents a decrease of 23.6% from the prior year.

Capital Expenditures

$28K

YoY+33.7%

5Y CAGR-29.3%

Geovax Labs Inc invested $28K in capex in fiscal year 2025, funding long-term assets and infrastructure. This represents an increase of 33.7% from the prior year.

Share Buybacks

Not reported for fiscal year 2025.

GOVXW Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GOVXW quarterly income statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Revenue	N/A	$2.5M-37.1%	$4.0M	$0-100.0%	$82K-78.9%	$386K-78.9%	$1.8M+55.1%	$1.2M+22.1%	$963K-10.4%	$1.1M+29.7%	$829K	N/A	N/A	N/A	N/A	N/A
R&D Expenses	N/A	$18.1M-23.6%	$23.7M+14.4%	$20.7M+127.1%	$9.1M-41.3%	$15.6M+536.3%	$2.4M+27.9%	$1.9M+1.7%	$1.9M-6.9%	$2.0M+2.4%	$2.0M+16.4%	$1.7M-6.6%	$1.8M-37.8%	$2.9M-4.2%	$3.0M-28.8%	$4.3M
SG&A Expenses	N/A	$6.0M+11.5%	$5.4M-10.6%	$6.0M+20.8%	$5.0M+39.4%	$3.6M+62.9%	$2.2M+34.1%	$1.6M-0.6%	$1.6M+33.7%	$1.2M-42.2%	$2.1M+49.1%	$1.4M-20.9%	$1.8M+0.9%	$1.8M+2.2%	$1.8M-41.0%	$3.0M
Operating Income	N/A	-$21.6M+13.9%	-$25.1M+6.0%	-$26.7M-90.6%	-$14.0M+25.2%	-$18.7M-565.5%	-$2.8M-18.7%	-$2.4M+7.4%	-$2.6M-17.9%	-$2.2M+33.6%	-$3.3M-21.5%	-$2.7M+1.6%	-$2.7M-19.6%	-$2.3M-7.0%	-$2.1M+8.9%	-$2.3M
Interest Expense	N/A	$0-100.0%	$21K	$0	$0-100.0%	$1K-99.1%	$144K+3093.0%	$4K+73.6%	$3K	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Income Tax	N/A	$0	N/A	N/A	N/A	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Net Income	N/A	-$21.5M+14.1%	-$25.0M+3.8%	-$26.0M-85.2%	-$14.0M+24.5%	-$18.6M-527.8%	-$3.0M-24.8%	-$2.4M+7.4%	-$2.6M-18.0%	-$2.2M+33.7%	-$3.3M-21.7%	-$2.7M+1.6%	-$2.7M-19.6%	-$2.3M-7.0%	-$2.1M+9.0%	-$2.3M

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Revenue	$0	N/A	$0-100.0%	$852K-47.9%	$1.6M	N/A	$2.8M+827.7%	$301K
R&D Expenses	$3.9M	N/A	$5.0M+6.7%	$4.7M-11.7%	$5.4M	N/A	$7.4M+73.1%	$4.3M
SG&A Expenses	$1.4M	N/A	$1.3M-13.8%	$1.5M-8.6%	$1.7M	N/A	$1.2M+14.3%	$1.1M
Operating Income	-$5.3M	N/A	-$6.4M-17.6%	-$5.4M-0.3%	-$5.4M	N/A	-$5.9M-15.7%	-$5.1M
Interest Expense	N/A	N/A	$0	$0	N/A	N/A	$14K+93.1%	$7K
Income Tax	$0	N/A	N/A	N/A	$0	N/A	N/A	N/A
Net Income	-$5.3M	N/A	-$6.3M-17.7%	-$5.4M-0.2%	-$5.4M	N/A	-$5.8M-14.8%	-$5.1M

Not reported in any period shown, so not listed: Cost of Revenue, Gross Profit, EPS (Diluted).

GOVXW Balance Sheet

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GOVXW quarterly balance sheet

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Total Assets	$6.3M-22.2%	$8.2M-12.1%	$9.3M-70.4%	$31.3M+165.7%	$11.8M+13.5%	$10.4M+2116.8%	$469K-27.0%	$642K+31.0%	$490K-19.7%	$610K-54.2%	$1.3M-0.1%	$1.3M-53.0%	$2.8M+92.1%	$1.5M-10.2%	$1.6M
Current Assets	$5.3M-33.0%	$7.9M+0.6%	$7.9M-72.8%	$28.9M+148.8%	$11.6M+13.6%	$10.2M+2188.4%	$447K-27.8%	$620K+38.3%	$448K-17.7%	$544K-56.0%	$1.2M+0.9%	$1.2M-54.6%	$2.7M+100.7%	$1.3M-5.2%	$1.4M
Cash & Equivalents	$3.1M-44.0%	$5.5M-14.7%	$6.5M-76.6%	$27.6M+141.7%	$11.4M+15.6%	$9.9M+3388.3%	$283K+9.1%	$260K-17.0%	$313K-31.1%	$454K-57.2%	$1.1M-3.7%	$1.1M-56.2%	$2.5M+142.7%	$1.0M-11.3%	$1.2M
Accounts Receivable	$0-100.0%	$659K	$0	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Liabilities	$2.5M-19.0%	$3.1M-11.7%	$3.5M-25.9%	$4.7M-36.1%	$7.4M+801.2%	$825K-59.6%	$2.0M+22.8%	$1.7M+105.2%	$811K+119.4%	$370K+191.2%	$127K-32.1%	$187K-40.1%	$312K-4.5%	$327K-65.3%	$942K
Current Liabilities	$1.9M-37.7%	$3.1M-11.7%	$3.5M-25.9%	$4.7M-12.6%	$5.4M+570.8%	$810K-59.8%	$2.0M+24.1%	$1.6M+100.3%	$811K+119.4%	$370K+191.2%	$127K-32.1%	$187K-40.1%	$312K-4.5%	$327K-65.3%	$942K
Total Equity	$3.8M-24.2%	$5.0M-12.4%	$5.8M-78.3%	$26.6M+509.9%	$4.4M-54.4%	$9.6M+707.7%	-$1.6M-54.0%	-$1.0M-218.4%	-$321K-233.6%	$240K-80.0%	$1.2M+5.1%	$1.1M-54.6%	$2.5M+119.6%	$1.2M+63.6%	$704K
Retained Earnings	-$150.8M-16.6%	-$129.4M-23.9%	-$104.4M-33.1%	-$78.4M-21.8%	-$64.4M-40.5%	-$45.8M-6.9%	-$42.8M-5.9%	-$40.5M-6.8%	-$37.9M-6.1%	-$35.7M-10.1%	-$32.5M-9.0%	-$29.8M	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Total Assets	$3.0M-53.0%	$6.3M-5.8%	$6.7M+25.8%	$5.4M-50.6%	$10.8M+32.8%	$8.2M-26.6%	$11.1M+171.4%	$4.1M
Current Assets	$2.4M-54.3%	$5.3M-18.5%	$6.5M+26.9%	$5.1M-51.6%	$10.6M+33.7%	$7.9M-27.0%	$10.9M+182.8%	$3.8M
Cash & Equivalents	$1.3M-58.8%	$3.1M-38.4%	$5.0M+61.9%	$3.1M-58.4%	$7.4M+35.1%	$5.5M-35.9%	$8.6M+450.2%	$1.6M
Accounts Receivable	N/A	$0	$0-100.0%	$533K-64.4%	$1.5M+127.1%	$659K+20.4%	$548K+82.1%	$301K
Total Liabilities	$2.5M-1.1%	$2.5M+38.0%	$1.8M-27.9%	$2.5M-13.8%	$2.9M-5.5%	$3.1M+19.1%	$2.6M-59.3%	$6.4M
Current Liabilities	$2.3M+18.3%	$1.9M+6.2%	$1.8M-27.9%	$2.5M-13.8%	$2.9M-5.5%	$3.1M+19.1%	$2.6M-59.3%	$6.4M
Total Equity	$494K-87.1%	$3.8M-22.0%	$4.9M+73.9%	$2.8M-64.3%	$7.9M+56.4%	$5.0M-40.6%	$8.5M+468.3%	-$2.3M
Retained Earnings	-$156.1M-3.5%	-$150.8M-3.0%	-$146.4M-4.5%	-$140.1M-4.0%	-$134.7M-4.1%	-$129.4M-6.8%	-$121.1M-5.0%	-$115.3M

Not reported in any period shown, so not listed: Inventory, Goodwill, Long-Term Debt.

GOVXW Cash Flow Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type.

GOVXW quarterly cash flow statement

Metric	TTM	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Cash Flow	-$19.0M	-$21.5M+13.0%	-$24.7M+2.0%	-$25.2M-32.3%	-$19.0M-70.0%	-$11.2M-307.1%	-$2.8M-96.7%	-$1.4M+9.4%	-$1.5M+8.6%	-$1.7M+13.2%	-$1.9M+28.1%	-$2.7M-20.2%	-$2.3M-32.8%	-$1.7M+30.6%	-$2.4M-704.0%	-$304K
Capital Expenditures	$11K	$28K+33.7%	$21K-57.8%	$49K-63.5%	$134K+181.4%	$48K-69.6%	$157K+1961.4%	$8K	N/A	$4K	N/A	$16K-55.4%	$36K-59.0%	$87K	N/A	$12K
Free Cash Flow	-$19.1M	-$21.5M+12.9%	-$24.7M+2.1%	-$25.2M-31.6%	-$19.2M-70.4%	-$11.2M-286.7%	-$2.9M-106.8%	-$1.4M	N/A	-$1.7M	N/A	-$2.7M-19.1%	-$2.3M-28.3%	-$1.8M	N/A	-$316K
Investing Cash Flow	-$11K	-$28K-33.7%	-$21K+57.8%	-$49K+63.5%	-$134K-181.4%	-$48K+69.6%	-$157K-1961.4%	-$8K	N/A	-$4K	N/A	-$16K+55.4%	-$36K+59.0%	-$87K	N/A	-$12K
Financing Cash Flow	$12.9M	$19.1M-19.7%	$23.8M+484.6%	$4.1M-88.5%	$35.4M+176.5%	$12.8M+2.2%	$12.5M+774.8%	$1.4M-4.0%	$1.5M-4.0%	$1.6M+15.8%	$1.3M-50.0%	$2.7M+206.8%	$873K-73.2%	$3.3M+41.1%	$2.3M+471.0%	$404K

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Cash Flow	-$3.5M+28.7%	-$5.0M+20.1%	-$6.2M-43.3%	-$4.3M+27.3%	-$6.0M+23.1%	-$7.8M+16.6%	-$9.3M-379.0%	-$1.9M
Capital Expenditures	$0	$0	$0-100.0%	$11K-36.6%	$17K	$0-100.0%	$21K	$0
Free Cash Flow	-$3.5M+28.7%	-$5.0M+20.1%	-$6.2M-43.0%	-$4.3M+27.4%	-$6.0M+22.8%	-$7.8M+16.8%	-$9.3M-380.0%	-$1.9M
Investing Cash Flow	$0	$0	$0+100.0%	-$11K+36.6%	-$17K	$0+100.0%	-$21K	$0
Financing Cash Flow	$1.7M-43.3%	$3.0M-62.6%	$8.1M+3888536.4%	$209-100.0%	$7.9M+69.5%	$4.7M-71.4%	$16.3M+498.0%	$2.7M

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

GOVXW Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples.

GOVXW quarterly financial ratios

Metric	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17	FY16	FY15	FY14	FY13	FY12	FY11
Operating Margin	-869.3%	-635.8%	N/A	-17207.5%	-4862.7%	-154.5%	-201.8%	-266.1%	-202.2%	-394.9%	N/A	N/A	N/A	N/A	N/A
Net Margin	-862.3%	-632.0%	N/A	-17198.3%	-4817.2%	-162.2%	-201.6%	-265.8%	-201.8%	-394.7%	N/A	N/A	N/A	N/A	N/A
Return on Equity	-561.2%-66.1pp	-495.0%-44.5pp	-450.5%-397.8pp	-52.7%+373.1pp	-425.8%-394.9pp	-30.9%	N/A	N/A	N/A	-1361.1%-1137.9pp	-223.3%+15.2pp	-238.5%-148.1pp	-90.4%+95.1pp	-185.5%+148.0pp	-333.5%
Return on Assets	-338.5%-32.0pp	-306.4%-26.7pp	-279.7%-235.0pp	-44.7%+112.7pp	-157.4%-129.0pp	-28.5%+477.1pp	-505.6%-106.9pp	-398.7%+44.0pp	-442.7%+93.5pp	-536.2%-334.2pp	-202.0%+3.1pp	-205.0%-124.6pp	-80.5%+64.0pp	-144.5%-1.8pp	-142.7%
Current Ratio	2.74+0.2x	2.55+0.3x	2.24-3.9x	6.10+4.0x	2.14-10.5x	12.63+12.4x	0.22-0.2x	0.38-0.2x	0.55-0.9x	1.47-8.3x	9.74+3.2x	6.55-2.1x	8.64+4.5x	4.11+2.6x	1.51
Debt-to-Equity	0.660.0x	0.620.0x	0.61+0.4x	0.18-1.5x	1.70+1.6x	0.09	N/A	N/A	N/A	1.54+1.4x	0.11-0.1x	0.160.0x	0.12-0.2x	0.28-1.1x	1.34
FCF Margin	-863.8%	-624.5%	N/A	-23507.2%	-2916.8%	-159.4%	-119.6%	N/A	-157.4%	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q1'26	Q4'25	Q3'25	Q2'25	Q1'25	Q4'24	Q3'24	Q2'24
Operating Margin	N/A	N/A	N/A	-635.8%	-330.2%	N/A	-209.9%	-1683.6%
Net Margin	N/A	N/A	N/A	-630.1%	-327.3%	N/A	-208.5%	-1684.2%
Return on Equity	-1065.7%	N/A	-128.8%+61.6pp	-190.3%-122.5pp	-67.8%	N/A	-68.4%	N/A
Return on Assets	-176.4%	N/A	-93.9%+6.5pp	-100.4%-50.9pp	-49.5%	N/A	-52.3%+71.3pp	-123.7%
Current Ratio	1.06-1.7x	2.74-0.8x	3.57+1.5x	2.03-1.6x	3.62+1.1x	2.55-1.6x	4.17+3.6x	0.60
Debt-to-Equity	5.04+4.4x	0.66+0.3x	0.37-0.5x	0.90+0.5x	0.37-0.2x	0.62+0.3x	0.31	N/A
FCF Margin	N/A	N/A	N/A	-509.8%	-365.5%	N/A	-334.0%	-645.6%

Not reported in any period shown, so not listed: Gross Margin.

Reported as filed but not readable as a share of revenue in the periods where the ratio runs further from zero than a revenue base allows; no change figure is given where either compared period is one of those: Operating Margin, Net Margin, FCF Margin.

Similar Companies

Estrella Immunopharma ESLAW

Briacell Therapeutics Corp BCTXW

Celularity Inc CELUW

Pasithea Therapeutics Corp KTTAW

NKGen Biotech NKGNW

Where Geovax Labs Inc Ranks

Frequently Asked Questions

What is Geovax Labs Inc's annual revenue?

Geovax Labs Inc (GOVXW) reported $2.5M in total revenue for fiscal year 2025. This represents a -37.1% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Geovax Labs Inc's revenue growing?

Geovax Labs Inc (GOVXW) revenue declined by 37.1% year-over-year, from $4.0M to $2.5M in fiscal year 2025.

Is Geovax Labs Inc profitable?

No, Geovax Labs Inc (GOVXW) reported a net income of -$21.5M in fiscal year 2025.

What is Geovax Labs Inc's EBITDA?

Geovax Labs Inc (GOVXW) had EBITDA of -$21.6M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Geovax Labs Inc's return on equity (ROE)?

Geovax Labs Inc (GOVXW) has a return on equity of -561.2% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Geovax Labs Inc's free cash flow?

Geovax Labs Inc (GOVXW) recorded an outflow of $21.5M in free cash flow during fiscal year 2025. This represents a 12.9% change compared to the previous fiscal year. Free cash flow represents the cash a company generates after accounting for capital expenditures, and is widely used to assess financial flexibility and shareholder value.

What is Geovax Labs Inc's operating cash flow?

Geovax Labs Inc (GOVXW) recorded an outflow of $21.5M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Geovax Labs Inc's total assets?

Geovax Labs Inc (GOVXW) had $6.3M in total assets as of fiscal year 2025, including both current and long-term assets.

What are Geovax Labs Inc's capital expenditures?

Geovax Labs Inc (GOVXW) invested $28K in capital expenditures during fiscal year 2025, funding long-term assets and infrastructure.

How much does Geovax Labs Inc spend on research and development?

Geovax Labs Inc (GOVXW) invested $18.1M in research and development during fiscal year 2025.

How many shares does Geovax Labs Inc have outstanding?

Geovax Labs Inc (GOVXW) had 2M shares outstanding as of fiscal year 2025.

What is Geovax Labs Inc's current ratio?

Geovax Labs Inc (GOVXW) had a current ratio of 2.74 as of fiscal year 2025, which is generally considered healthy.

What is Geovax Labs Inc's debt-to-equity ratio?

Geovax Labs Inc (GOVXW) had a debt-to-equity ratio of 0.66 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Geovax Labs Inc's return on assets (ROA)?

Geovax Labs Inc (GOVXW) had a return on assets of -338.5% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

How does Geovax Labs Inc's liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Geovax Labs Inc (GOVXW) held $3.1M in cash, cash equivalents and investments, and reported an operating cash outflow of $21.5M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Geovax Labs Inc's Piotroski F-Score?

Geovax Labs Inc (GOVXW) has a Piotroski F-Score of 1 out of 7 computable signals; 2 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Geovax Labs Inc's earnings high quality?

Geovax Labs Inc (GOVXW) reported a net loss of $21.5M while operations used $21.5M of cash. With neither figure positive, the ratio between the two carries no quality signal. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

How financially healthy is Geovax Labs Inc?

Geovax Labs Inc (GOVXW) scores 31 out of 100 on our Financial Health Score, indicating weak standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.